-
1
Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
2
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
3
-
4
Current trends in peanut allergy immunotherapy: a review
Published 2024-04-01Subjects: Get full text
Article -
5
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
Published 2025-01-01Subjects: Get full text
Article -
6
Efficacy and safety of sublingual immunotherapy using a combination of Dermatophagoides pteronyssinus and Blomia tropicalis extracts in patients with allergic rhinitis: A randomize...
Published 2025-02-01Subjects: “…Allergen immunotherapy…”
Get full text
Article -
7
CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
Published 2025-02-01Subjects: Get full text
Article -
8
Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II
Published 2025-01-01Subjects: Get full text
Article -
9
Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist
Published 2025-01-01Subjects: Get full text
Article -
10
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
11
Immune Checkpoint Blockade in Melanoma – Earlier is Better?
Published 2024-09-01Subjects: Get full text
Article -
12
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection
Published 2024-11-01Subjects: Get full text
Article -
13
Neoantigen immunotherapy: a novel treatment for bladder cancer
Published 2025-01-01Subjects: Get full text
Article -
14
-
15
-
16
-
17
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
18
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Published 2025-01-01Subjects: “…Cancer immunotherapy…”
Get full text
Article -
19
-
20
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention
Published 2025-12-01Subjects: Get full text
Article